Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. [PDF]
Hinz TK +11 more
europepmc +1 more source
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley +1 more source
Molecular glue that stabilizes the LRPPRC-MET-G4 interaction complex to drive MET downregulation. [PDF]
Li YP +16 more
europepmc +1 more source
Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them. [PDF]
Pagano Mariano M +8 more
europepmc +1 more source
Atypical Spitz Tumor With RET::MXT1 Gene Rearrangement in a 14-Year-Old Girl: An Integrated Histopathologic, Immunohistochemical, and Molecular Diagnostic Approach. [PDF]
Di Lorito A +7 more
europepmc +1 more source
Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer. [PDF]
Yoshichika R +10 more
europepmc +1 more source
From ecDNA structure to tumor immune escape and therapeutic resistance: evidence, uncertainty, and clinical priorities. [PDF]
Rehman SU.
europepmc +1 more source
Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review. [PDF]
Sato Y +8 more
europepmc +1 more source

